Improved Induction and Maintenance Immunosuppression in Kidney Transplantation

NCT00556933 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

End-stage Renal Disease

Interventions

DRUG: rabbit anti-thymocyte globulin - single dose
DRUG: mycophenolate mofetil
DRUG: rabbit anti-thymocyte globulin - 4 doses
DRUG: sirolimus
DRUG: tacrolimus

Sponsor

University of Nebraska

Collaborators

[object Object]